Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

First day of trading in FluoGuide’s shares and warrants at Spotlight Stock Market

Today is the first day of trading in FluoGuide A/S’s ("FluoGuide") shares and warrants of series TO 1. FluoGuide’s shares are traded under the ticker "FLUO" with ISIN DK0061123312 and FluoGuide’s warrants of series TO 1 are traded under the ticker “FLUO TO1” with ISIN DK0061138773.Ahead of the listing at Spotlight Stock Market, FluoGuide has conducted a successful IPO which has provided the company approx. DKK 15.9 million before issue costs and approx. 1,500 new shareholders. The issue funds will primarily finance advancing the first product FG001 towards the market and broad clinical use.

2cureX publishes the annual report for the fiscal year 2018

The Board of Directors and the CEO of 2cureX AB ("2cureX") hereby publish the annual report for the fiscal year 2018. The annual report and associated audit report are available as an attached file or on the company's website  (www.2curex.com). Please note that the annual report of 2cureX is only available in Swedish.Certified Adviser Sedermera FondkommissionE-mail: ca@sedermera.sePhone: +46 40 615 14 15 For more information about 2cureX: Ole Thastrup, CEO         E-mail: ot@2cureX.comPhone: +45 22 11 53 99              URL: www.2curex.com About 2cureX 2cureX has

EU highlights SenzaGen's animal-free test – the world's first of its kind to assess whether chemical substances can cause respiratory allergies

Today, International Asthma Day is being recognized worldwide. Asthma is a global health problem - over 300 million have a diagnosis and nearly 1 million Swedes are affected – a number expected to increase. The EU has invested in the development of the world's first in-vitro test for respiratory sensitization. GARD®air was developed by the Swedish company SenzaGen and predicts whether chemical substances can cause allergic reactions in the airways. The test, which is based on Artificial Intelligence and Genomics, enables not only development of safe products but also preventative measures –

Letters take center stage in Storytel’s new visual identity

Storytel’s new look is the product of a thorough analysis of Storytel’s central values and vision, and is the result of the company’s need to reach out to global markets in different areas of the world. B-Reel Creative Agency designed the new look after reaching deep into Storytel’s company culture and mission, all the way down to its stories. A more creative and empathetic world with great stories to be shared and enjoyed anywhere and anytime ––  Storytel´s vision, as well as its strong corporate culture, have been central part in the extensive work B-Reel and Storytel have put

NOTICE OF ANNUAL GENERAL MEETING IN Q-FREE ASA

(This notice is a translation of the Norwegian notice of the General meeting. If any deviation between the two versions, the Norwegian version shall prevail.) Notice is hereby given that the Annual General meeting in Q-Free ASA will be held on Tuesday 28 May 2019 at 10.00 CET at the Company's office in Parkveien 55, Oslo. The notice and papers, together with the notice of attendance and proxy form, have been sent to all shareholders with known addresses registered in the Norwegian Security Depository (VPS) as of 6 May 2019. In accordance with the Company's Articles of Association,

Continued strong growth in Sweden, but lower total sales during the quarter

First quarter · Net sales reached SEK 13.3 (15.1) million. · Result after tax came in at SEK -12.2 (-10.1) million. · Earnings per share, basic and diluted, were SEK -0.09 (-0.11) · Cash and cash equivalents were SEK 53.9 (8.2) million. Significant events in Q1  · Enzymatica presented the final results from the German multicenter study for assessment of ColdZyme® during the 2018 cold season. The convincing results strengthen and broaden ColdZyme’s product claims. · Enzymatica initiated a double-blind, placebo-controlled study to evaluate the effects of ColdZyme on

Managers’ transactions

Nordea Bank Abp – Stock exchange release – Managers’ transactions Transaction notification under Article 19 of the EU Market Abuse Regulation Person subject to the notification requirementName: JØRGENSEN, TORSTEN HAGENPosition: Other senior managerIssuer: Nordea Bank AbpLEI: 529900ODI3047E2LIV03 Notification type: INITIAL NOTIFICATIONReference number: 529900ODI3047E2LIV03_20190501090627_2 Transaction date: 2019-05-02Venue: NASDAQ COPENHAGEN A/S (XCSE)Instrument type: SHAREISIN: FI4000297767Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE OR

Scout Gaming signs agreement with Digitain

Scout Gaming has entered into an agreement with platform provider Digitain. The agreement stipulates the distribution of Scout Gaming's game products. Digitain is a privately held company providing Omni-channel iGaming software solutions to the online, mobile and land-based verticals. Digitain has over 1,000 employees, 55+ partners worldwide, and more than 400 land-based bet shops worldwide."Digitain is among one of the larger platform providers and will make a great potential contribution to our network. This clearly states that Scout Gaming is the first-hand choice when it comes to

Notification in accordance with the Finnish Securities Market Act Chapter 9 § 5: BlackRock, Inc.’s holding in Wärtsilä Corporation

Wärtsilä Corporation, Stock exchange release, 7 May 2019 at 9:30 am EETNotification in accordance with the Finnish Securities Market Act Chapter 9 § 5: BlackRock, Inc.’s holding in Wärtsilä CorporationBlackRock, Inc. has informed Wärtsilä Corporation it has crossed below the 5% disclosure limit on shares and voting rights on 3 May 2019. Following the transaction BlackRock, Inc. owns 4.95% of Wärtsilä’s shares and voting rights, while its total holding in Wärtsilä Corporation corresponds to 5.18%.Total position of BlackRock, Inc. and its funds subject to the notification: +------------

Interim report – First quarter 2019

ANNOUNCEMENT NO. 13 - 7 MAY 2019 Attached please find the full interim report as PDF file Today, the Board of Directors approved the interim report for the first quarter 2019. The report contains the following highlights: Results Adjusted Result* for Q1 2019: USD 7 million (Q1 2018: USD 9 million) · Dry Operator: USD -3 million (USD 3 million) · Dry Owner: USD 0 million (USD 5 million) · Tankers: USD 10 million (USD 0 million) Loss from sale of vessels: USD 12 million Adjusted Result excluding effect of IFRS 16: USD 10 million *”Profit/loss for the period”

Managers’ transactions

Nordea Bank Abp – Stock exchange release – Managers’ transactionsTransaction notification under Article 19 of the EU Market Abuse RegulationPerson subject to the notification requirementName: VON KOSKULL, CASPERPosition: Chief Executive OfficerIssuer: Nordea Bank AbpLEI: 529900ODI3047E2LIV03Notification type: INITIAL NOTIFICATION Reference number: 529900ODI3047E2LIV03_20190503105547_2Transaction date: 2019-05-02Venue: NASDAQ HELSINKI LTD (XHEL)Instrument type: SHAREISIN: FI4000297767Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE OR REMUNERATION

Data from the remetinostat phase II study in basal cell carcinoma patients to be presented at the 2019 SID Annual meeting

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announces that data from the investigator-initiated study evaluating the effects of remetinostat in basal cell carcinoma patients, will be presented during the 2019 Society for Investigative Dermatology (SID) annual meeting in Chicago, USA.Data will be presented on a poster and orally on May 10 and 11, respectively. The title of the abstract is: “An Open-Label Phase 2 Clinical Trial of Topical Remetinostat Gel for Basal Cell Carcinoma”.Authors: Nicole Urman B.S., Shaundra Eichstadt M.D., Hanh Do B.S., Amar Mirza B.S., Irene

AcadeMedia’s interim report July 2018 – March 2019

Third quarter (January – March 2019) · Net sales increased by 5.7 percent and amounted to SEK 3,135 million (2,967). Organic growth, including bolt-on acquisitions, was 4.5 percent. · Operating profit (EBIT) increased by 10.5 percent to SEK 231 million (209). Retroactive revenues from prior years amounted to SEK 20 million and is included in items affecting comparability. Adjusted for items affecting comparability, operating profit was SEK 210 million (214). · Net profit for the period was SEK 172 million (152). · Cash flow from operating activities amounted to SEK 129 million

Calquence PhIII ASCEND trial met primary endpoint

7 May 2019 07:00 BST Calquence Phase III ASCEND trial met primary endpoint at interim analysisin relapsed or refractory chronic lymphocytic leukaemia and will stop early Calquence significantly increased the timepatients live without disease progression AstraZeneca today announced positive results from the Phase III ASCEND trial of Calquence(acalabrutinib) in previously-treated patients with chronic lymphocytic leukaemia (CLL). Results showed a statistically-significant and clinically-meaningful improvement in progression-free survival (PFS) with Calquence monotherapy compared

Aiven Closes €8 Million Series A Round on Back of Strong Performance

Helsinki, Finland Aiven has completed an €8 million Series A funding round to enhance its leading cloud data platform with more integrated solutions and to accelerate international growth. "We see a tremendous number of companies around the world now implementing their new real-time data platforms in the cloud. The new funding will allow us to better cater to their requirements,” states Oskari Saarenmaa, co-founder and CEO at Aiven. The round was led by Earlybird Venture Capital with participation from Lifeline Ventures and Nokia chairman Risto Siilasmaa. Hendrik Brandis, partner

Flexion Mobile continues to attract games from China

signs new mid-tier game to be launched during the summerLONDON, 7th of May, 2019 – Flexion Mobile Plc (Nasdaq: FLEXM) , the London-based Android games distribution company today announced the signing of a new mid-tier title from China. The game is an action-packed space strategy game which is generating approximately USD 500,000 per month in Google Play.  The distribution agreement allows Flexion to distribute the game in all its main channels including Amazon and Samsung. It is planned to go live during the 2nd financial quarter (July-Sep). "Our China team

City of Borås stad selects hyper-converged data centre solution from Proact

The City of Borås in Sweden has selected Proact as its new supplier of IT infrastructure. The City’s data centre will now be updated with a next-generation solution that reduces footprint while also saving energy and easing daily operational management.As part of Borås’ strategic development initiatives, the City is making this investment to increase capacity for several enterprise applications. The City’s objective is to implement new digital services that benefit the public, as well as more than 10,000 employees.  By opting for a hyper-converged solution, a large number of existing

Hexagon Interim Report 1 January - 31 March 2019

First Quarter 2019- Net sales increased by 10 per cent to 916.5 MEUR (834.7). Using fixed exchange rates and a comparable group structure (organic growth), net sales increased by 4 per cent- Operating earnings (EBIT1) increased by 11 per cent to 220.5 MEUR (198.3)- Earnings before taxes, excluding non-recurring items, amounted to 212.9 MEUR (192.3)- Net earnings, excluding non-recurring items, amounted to 174.6 MEUR (157.7)- Earnings per share, excluding non-recurring items, increased by 12 per cent to 0.48 EUR (0.43)- Operating cash flow, excluding non-recurring items,

Ripasso Energy AB (to be renamed to Swedish Stirling AB): Q1, 2019 report

Clean tech company Ripasso Energy AB (to be renamed to Swedish Stirling AB) publishes its Q1, 2019 report today.Swedish clean tech company Ripasso Energy AB is publishing its interim report for the period 01-01-2019 – 31-03-2019 today. The report is available for download in its entirety on the company’s website. Significant events during the period include the following:  · Ripasso Energy AB ships the first PWR BLOK 400-F unit of the seven ordered by South African ferrochrome producer Afarak Mogale. Installation and commissioning take place in Q1 as planned · Ripasso Energy AB

Ovzon and Hispasat signs strategic agreement to provide a powerful portable connectivity service

Ovzon and Hispasat, a Spanish telecommunications satellite operator, have entered into a strategic partnership agreement to jointly offer a high-capacity portable broadband solution. The agreement leverages both companies’ technologies, industry expertise, resources and market presence to promote joint growth. Hispasat will provide the satellite capacity to power the services in Europe and Latin America, where the companies will jointly market this solution.The agreement includes technical collaboration across the organizations as well as joint go-to-market initiatives for fixed and

NCC to build clinic for St. Olavs Hospital in Trondheim

NCC has been commissioned by St. Olavs Hospital HF to build a high-security clinic for psychiatric care at Østmarka in Trondheim, Norway. The order value is almost SEK 300 million and the assignment will be carried out as a turnkey contract. Illustration: Karlsson, Schønherr and RATIO The new building will take over all of the functions currently housed in the hospital at Brøset in Trondheim for psychiatric care.  “This is the first time a regional high-security building is being constructed in Norway, and it offers us an opportunity to build a clinic that is functional and

Read original

PowerCell to open sales office in China

PowerCell has decided to open a sales office in China to better meet the strong increase in fuel cell technology in the Chinese market.The English version is an in house-translation. In case of any discrepancy, the Swedish text will prevail. PowerCell has already sales offices in Japan, South Korea and South Africa and a German subsidiary. PowerCell has initiated the process to find suitable location and recruit personnel for its sales office in China. China is a highly interesting market for PowerCell both due to its size and the Chinese Government’s measures to support an increased

Caverion wins building technology modernisation project for Aalto University in Helsinki

Caverion Corporation Investor news 7 May 2019 at 9:00 a.m. EESTCaverion wins building technology modernisation project for Aalto University in Helsinki   [ AkiPekka Sinikoski Aaltoyliopisto] Caverion has won a contract with the general contractor Fira to modernise all building systems of the former main building of Aalto University School of Business in Helsinki, Finland. The value of the contract for Caverion is approximately EUR 8.4 million. The size of the building is nearly 16,000 m2, and it is owned by KOy Runeberginkatu 14 - 16. The functionalist former main building of the

myFC Holding’s Board of Directors appoints Peter Friedrichsen as new President and CEO

myFC Holding’s Board of Directors appoints Peter Friedrichsen as new President and CEO. He joins the company immediately. Peter Friedrichsen replaces Björn Westerholm, who has been President and CEO since 2007.Peter Friedrichsen has a Master of Science from Chalmers Institute of Technology, During the 90’s he was mainly engaged with the automotive industry, primarily with Scania. After this he has amongst others been President of Max Move, a Swedish start-up. From 2006 to 2019 he was President, CEO and Partner of Bergenstråhle & Partners, a Swedish strategy consulting firm focused on

There are no items matching the current filter
There are no more items matching the current filter
Back to top